XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   77,456,180    
Beginning balance (in shares)   77,464,781    
Beginning balance at Dec. 31, 2018 $ 44,207 $ 77 $ 230,154 $ (186,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (6,480)     (6,480)
Share-based compensation 326   326  
Sales of common stock under 2014 ESPP (in shares)   8,601    
Sales of common stock under 2014 ESPP 7   7  
Ending balance (in shares) at Mar. 31, 2019   77,464,781    
Ending balance at Mar. 31, 2019 38,060 $ 77 230,487 (192,504)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   101,267,578    
Beginning balance at Dec. 31, 2018 44,207 $ 77 230,154 (186,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (73,947)      
Ending balance (in shares) at Sep. 30, 2019   101,267,578    
Ending balance at Sep. 30, 2019 $ 2,467 $ 101 262,337 (259,971)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   77,464,781    
Beginning balance (in shares) 101,265,896      
Beginning balance at Mar. 31, 2019 $ 38,060 $ 77 230,487 (192,504)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (54,335)     (54,335)
Share-based compensation 356   356  
Exercise of stock options (in shares)   30,000    
Exercise of stock options 45   45  
Exercise of common stock warrants (in shares)   3,361,115    
Exercise of common stock warrants 3,434 $ 4 3,430  
Issuance of common stock under ATM offering, net of issuance costs (in shares)   20,410,000    
Issuance of common stock under ATM offering, net of issuance costs $ 27,809 $ 20 27,789  
Ending balance (in shares) at Jun. 30, 2019 101,265,896      
Ending balance at Jun. 30, 2019 $ 15,369 $ 101 262,107 (246,839)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares) 101,265,896      
Beginning balance (in shares)   101,267,578    
Net income (loss) $ (13,132)     (13,132)
Share-based compensation 229   229  
Issuance of common stock under ATM offering, net of issuance costs (in shares)   1,682    
Issuance of common stock under ATM offering, net of issuance costs 1 $ 0 1  
Ending balance (in shares) at Sep. 30, 2019   101,267,578    
Ending balance at Sep. 30, 2019 2,467 $ 101 262,337 (259,971)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   101,267,578    
Beginning balance (in shares)   106,801,409    
Beginning balance (in shares)   109,991,553    
Beginning balance at Dec. 31, 2019 (26,700) $ 107 266,717 (293,524)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 41,564     41,564
Share-based compensation 407   407  
Sales of common stock under 2014 ESPP (in shares)   2,785    
Sales of common stock under 2014 ESPP 1   1  
Issuance of common stock under ATM offering, net of issuance costs (in shares)   3,187,359    
Issuance of common stock under ATM offering, net of issuance costs 3,179 $ 3 3,176  
Ending balance (in shares) at Mar. 31, 2020   109,991,553    
Ending balance at Mar. 31, 2020 18,451 $ 110 270,301 (251,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   123,645,007    
Beginning balance at Dec. 31, 2019 (26,700) $ 107 266,717 (293,524)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ (7,388)      
Exercise of stock options (in shares) 0      
Exercise of common stock warrants (in shares) 0      
Ending balance (in shares) at Sep. 30, 2020   123,645,007    
Ending balance at Sep. 30, 2020 $ (16,553) $ 123 284,236 (300,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   109,991,553    
Beginning balance (in shares)   116,627,653    
Beginning balance at Mar. 31, 2020 18,451 $ 110 270,301 (251,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (26,344)     (26,344)
Share-based compensation 491   491  
Issuance of common stock under ATM offering, net of issuance costs (in shares)   6,636,100    
Issuance of common stock under ATM offering, net of issuance costs 4,774 $ 6 4,768  
Ending balance (in shares) at Jun. 30, 2020   116,627,653    
Ending balance at Jun. 30, 2020 (2,628) $ 116 275,560 (278,304)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   116,627,653    
Beginning balance (in shares)   123,645,007    
Net income (loss) (22,608)     (22,608)
Share-based compensation 453   453  
Sales of common stock under 2014 ESPP (in shares)   25,401    
Sales of common stock under 2014 ESPP 9   9  
Issuance of common stock under ATM offering, net of issuance costs (in shares)   6,991,953    
Issuance of common stock under ATM offering, net of issuance costs 8,221 $ 7 8,214  
Ending balance (in shares) at Sep. 30, 2020   123,645,007    
Ending balance at Sep. 30, 2020 $ (16,553) $ 123 $ 284,236 $ (300,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   123,645,007